When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.
source: pixabay.com

When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.

As originally reported in the Cincinnati Children's, Brittney writes how she came into the world of rare diseases when her and her husband Michael decided to adopt a baby who…

Continue Reading When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.
Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
source: pixabay.com

Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities

As originally reported in Biospace, two research networks dedicated to forming bridges between rare disease research around the world will share their niches to promote discovery for rare diseases. TriNetX…

Continue Reading Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
First Treatment for Transthyretin Amyloidosis Cardiomyopathy Approved in Europe
source: pixabay.com

First Treatment for Transthyretin Amyloidosis Cardiomyopathy Approved in Europe

As originally reported in Pfizer, the European Commission has just approved the first treatment option ever available to treat transthyretin amyloidosis cardiomyopathy (ATTR-CM). The medication, VYNDAQEL, taken orally once daily,…

Continue Reading First Treatment for Transthyretin Amyloidosis Cardiomyopathy Approved in Europe
A Pilot DNA Therapy for Recurrent Respiratory Papillomatosis (RRP) Shows Promising Results
source: pixabay.com

A Pilot DNA Therapy for Recurrent Respiratory Papillomatosis (RRP) Shows Promising Results

As originally reported in BioPortfolio, a novel DNA therapy for patients with HPV 6 who experience recurrent respiratory papillomatosis (RRP) has concluded its first clinical trial with promising results. As…

Continue Reading A Pilot DNA Therapy for Recurrent Respiratory Papillomatosis (RRP) Shows Promising Results
He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS
source: pixabay.com

He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS

As originally reported in ArcaMax,  when you get a diagnosis for a terminal rare disease, a wave of emotions crashes over life. Brian Wallach emerged clutching 'hope.' In 2017, Brian,…

Continue Reading He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS

“We Were Most Excited to Someday Not Take Pills and to Not Do Vest Therapies”: Her Lifetime With Cystic Fibrosis

As originally reported in Cystic Fibrosis Life Foundation, Martha has spent her 24 years of life with cystic fibrosis. She was born with the rare disease which means for a…

Continue Reading “We Were Most Excited to Someday Not Take Pills and to Not Do Vest Therapies”: Her Lifetime With Cystic Fibrosis
ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision
source: pixabay.com

ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision

As originally reported in NewsRoom, the US's political volatility over the past years has thrown many policies and legislation into debate. While switching the party in both the executive and…

Continue Reading ICYMI: The Affordable Care Act May be Ruled Unconstitutional: Patient Groups Unite to Ask for a Prompt Decision

“If You’ve Grown Up With Your Disease From Day One, You Never Know What It’s Like to be Healthy.” Patient Stories in the #IAmNumber17 Campaign

As originally reported in PR Week; pharma company Takeda has been joined a plethora of rare patients groups to create the 'I am Number 17 ' campaign which features 17…

Continue Reading “If You’ve Grown Up With Your Disease From Day One, You Never Know What It’s Like to be Healthy.” Patient Stories in the #IAmNumber17 Campaign
ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life
source: pixabay.com

ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life

As originally reported in Euronews, there is limited supply of expensive medicines for rare diseases, so it can be difficult to prioritize which patients will have their lives saved when…

Continue Reading ICYMI: The Manufacturer of Spinal Muscular Atrophy Drug Zolgensma has Made a Lottery for Life

Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation

A medication that works for some patients with a rare disease may not be effective for others, even with the same disease. For rare diseases, this is important because sample…

Continue Reading Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation